TARC/CCL17 gene polymorphisms and expression associated with susceptibility and coronary artery aneurysm formation in Kawasaki disease

Chiu Ping Lee, Ying Hsien Huang, Yu Wen Hsu, Kuender D. Yang, Shu-Chen Chien, Hong Ren Yu, Ya Ling Yang, Chih Lu Wang, Wei Chiao Chang, Ho Chang Kuo

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background:Kawasaki disease (KD) is a systemic vasculitis of unknown etiology. Thymus and activation-regulated chemokine/chemokine ligand 17 (TARC/CCL17) is one of the Th2 chemokines and has been suggested as a candidate gene for conferring susceptibility to Th2 associated with allergy diseases. This study examined the correlation between gene polymorphisms and plasma levels of TARC/CCL17 in patients with KD and the outcomes of KD.Methods:A total of 381 KD patients and 564 controls were subjected to determination of five tagging single-nucleotide polymorphisms of TARC/CCL17. In addition, plasma TARC/CCL17 levels were measured by enzyme-linked immunosorbent assay.Results:Polymorphisms of TARC/CCL17 were significantly different between normal children and patients with KD. A allele of rs4784805 has better intravenous immunoglobulin (IVIG) treatment response to KD. Furthermore, plasma TARC/CCL17 levels were higher in KD patients than that in controls before IVIG treatment. After IVIG treatment, plasma TARC/CCL17 levels decreased significantly.Conclusion:This study provides the first evidence supporting the association between TARC/CCL17 polymorphisms, susceptibility of KD, and IVIG responses in KD patients.

Original languageEnglish
Pages (from-to)545-551
Number of pages7
JournalPediatric Research
Volume74
Issue number5
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Coronary Aneurysm
Mucocutaneous Lymph Node Syndrome
Coronary Vessels
Gene Expression
Intravenous Immunoglobulins
Chemokines
Chemokine CCL17
Systemic Vasculitis
Genes
Single Nucleotide Polymorphism
Hypersensitivity
Therapeutics
Enzyme-Linked Immunosorbent Assay
Alleles
Ligands

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

TARC/CCL17 gene polymorphisms and expression associated with susceptibility and coronary artery aneurysm formation in Kawasaki disease. / Lee, Chiu Ping; Huang, Ying Hsien; Hsu, Yu Wen; Yang, Kuender D.; Chien, Shu-Chen; Yu, Hong Ren; Yang, Ya Ling; Wang, Chih Lu; Chang, Wei Chiao; Kuo, Ho Chang.

In: Pediatric Research, Vol. 74, No. 5, 11.2013, p. 545-551.

Research output: Contribution to journalArticle

Lee, Chiu Ping ; Huang, Ying Hsien ; Hsu, Yu Wen ; Yang, Kuender D. ; Chien, Shu-Chen ; Yu, Hong Ren ; Yang, Ya Ling ; Wang, Chih Lu ; Chang, Wei Chiao ; Kuo, Ho Chang. / TARC/CCL17 gene polymorphisms and expression associated with susceptibility and coronary artery aneurysm formation in Kawasaki disease. In: Pediatric Research. 2013 ; Vol. 74, No. 5. pp. 545-551.
@article{6fc21618a8034eac845fe4cdf2815792,
title = "TARC/CCL17 gene polymorphisms and expression associated with susceptibility and coronary artery aneurysm formation in Kawasaki disease",
abstract = "Background:Kawasaki disease (KD) is a systemic vasculitis of unknown etiology. Thymus and activation-regulated chemokine/chemokine ligand 17 (TARC/CCL17) is one of the Th2 chemokines and has been suggested as a candidate gene for conferring susceptibility to Th2 associated with allergy diseases. This study examined the correlation between gene polymorphisms and plasma levels of TARC/CCL17 in patients with KD and the outcomes of KD.Methods:A total of 381 KD patients and 564 controls were subjected to determination of five tagging single-nucleotide polymorphisms of TARC/CCL17. In addition, plasma TARC/CCL17 levels were measured by enzyme-linked immunosorbent assay.Results:Polymorphisms of TARC/CCL17 were significantly different between normal children and patients with KD. A allele of rs4784805 has better intravenous immunoglobulin (IVIG) treatment response to KD. Furthermore, plasma TARC/CCL17 levels were higher in KD patients than that in controls before IVIG treatment. After IVIG treatment, plasma TARC/CCL17 levels decreased significantly.Conclusion:This study provides the first evidence supporting the association between TARC/CCL17 polymorphisms, susceptibility of KD, and IVIG responses in KD patients.",
author = "Lee, {Chiu Ping} and Huang, {Ying Hsien} and Hsu, {Yu Wen} and Yang, {Kuender D.} and Shu-Chen Chien and Yu, {Hong Ren} and Yang, {Ya Ling} and Wang, {Chih Lu} and Chang, {Wei Chiao} and Kuo, {Ho Chang}",
year = "2013",
month = "11",
doi = "10.1038/pr.2013.134",
language = "English",
volume = "74",
pages = "545--551",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - TARC/CCL17 gene polymorphisms and expression associated with susceptibility and coronary artery aneurysm formation in Kawasaki disease

AU - Lee, Chiu Ping

AU - Huang, Ying Hsien

AU - Hsu, Yu Wen

AU - Yang, Kuender D.

AU - Chien, Shu-Chen

AU - Yu, Hong Ren

AU - Yang, Ya Ling

AU - Wang, Chih Lu

AU - Chang, Wei Chiao

AU - Kuo, Ho Chang

PY - 2013/11

Y1 - 2013/11

N2 - Background:Kawasaki disease (KD) is a systemic vasculitis of unknown etiology. Thymus and activation-regulated chemokine/chemokine ligand 17 (TARC/CCL17) is one of the Th2 chemokines and has been suggested as a candidate gene for conferring susceptibility to Th2 associated with allergy diseases. This study examined the correlation between gene polymorphisms and plasma levels of TARC/CCL17 in patients with KD and the outcomes of KD.Methods:A total of 381 KD patients and 564 controls were subjected to determination of five tagging single-nucleotide polymorphisms of TARC/CCL17. In addition, plasma TARC/CCL17 levels were measured by enzyme-linked immunosorbent assay.Results:Polymorphisms of TARC/CCL17 were significantly different between normal children and patients with KD. A allele of rs4784805 has better intravenous immunoglobulin (IVIG) treatment response to KD. Furthermore, plasma TARC/CCL17 levels were higher in KD patients than that in controls before IVIG treatment. After IVIG treatment, plasma TARC/CCL17 levels decreased significantly.Conclusion:This study provides the first evidence supporting the association between TARC/CCL17 polymorphisms, susceptibility of KD, and IVIG responses in KD patients.

AB - Background:Kawasaki disease (KD) is a systemic vasculitis of unknown etiology. Thymus and activation-regulated chemokine/chemokine ligand 17 (TARC/CCL17) is one of the Th2 chemokines and has been suggested as a candidate gene for conferring susceptibility to Th2 associated with allergy diseases. This study examined the correlation between gene polymorphisms and plasma levels of TARC/CCL17 in patients with KD and the outcomes of KD.Methods:A total of 381 KD patients and 564 controls were subjected to determination of five tagging single-nucleotide polymorphisms of TARC/CCL17. In addition, plasma TARC/CCL17 levels were measured by enzyme-linked immunosorbent assay.Results:Polymorphisms of TARC/CCL17 were significantly different between normal children and patients with KD. A allele of rs4784805 has better intravenous immunoglobulin (IVIG) treatment response to KD. Furthermore, plasma TARC/CCL17 levels were higher in KD patients than that in controls before IVIG treatment. After IVIG treatment, plasma TARC/CCL17 levels decreased significantly.Conclusion:This study provides the first evidence supporting the association between TARC/CCL17 polymorphisms, susceptibility of KD, and IVIG responses in KD patients.

UR - http://www.scopus.com/inward/record.url?scp=84887438029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887438029&partnerID=8YFLogxK

U2 - 10.1038/pr.2013.134

DO - 10.1038/pr.2013.134

M3 - Article

C2 - 23942559

AN - SCOPUS:84887438029

VL - 74

SP - 545

EP - 551

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 5

ER -